NATIXIS

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1274981 PARIS, I0

Position in ALNY

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$5,649,936

-$10,168,183 QoQ

Shares Held

17,076

-57.1% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NATIXIS holds $79,787,364 across 30 Biotechnology names. ALNY ranks #3 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	55,307	$42,732,400
2	VRTX	Vertex Pharmaceuticals Inc / Ma	48,192	$21,519,655
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	17,076	$5,649,936
4	ERAS	Erasca, Inc.	163,192	$2,640,446
5	RARE	Ultragenyx Pharmaceutical Inc.	81,754	$1,712,746
6	COGT	Cogent Biosciences, Inc.	41,536	$1,598,720
7	CAI	Caris Life Sciences, Inc.	52,778	$943,670
8	TECH	BIO-TECHNE Corp	11,286	$589,806

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,649,936	17,076	-57.1%	Shares	Sole	2026-05-14
2025-12-31	$15,818,119	39,779	+13569.8%	Shares	Sole	2026-02-13
2024-06-30	$70,713	291	-57.3%	Shares	Sole	2024-08-13
2024-03-31	$101,924	682	-99.7%	Shares	Sole	2024-05-13
2022-09-30	$45,242,965	226,034	+2820.7%	Shares	Sole	2022-11-14
2022-06-30	$1,128,733	7,739	+227.1%	Shares	Sole	2022-08-12
2022-03-31	$386,344	2,366	-97.7%	Shares	Sole	2022-05-13
2021-12-31	$17,646,833	104,062	+1.5%	Shares	Sole	2022-02-14
2021-09-30	$19,356,045	102,516	+1110.1%	Shares	Sole	2021-11-12
2021-06-30	$1,436,173	8,472	+30.1%	Shares	Sole	2021-08-13
2021-03-31	$919,288	6,511	+227.8%	Shares	Sole	2021-05-14
2020-12-31	$258,120	1,986	-23.7%	Shares	Sole	2021-02-12
2020-09-30	$378,851	2,602	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.